Randomised study of the effects of fluoride and time on in situ remineralisation of acid-softened enamel.


Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 17 05 2018
accepted: 04 04 2019
pubmed: 19 4 2019
medline: 31 12 2019
entrez: 19 4 2019
Statut: ppublish

Résumé

This single-centre, randomised, crossover study used a short-term in situ dental erosion remineralisation model to explore the remineralisation of acid-softened enamel in the 4-h period immediately following brushing with an anti-erosion, dentin hypersensitivity test dentifrice containing 1150 ppm fluoride (as sodium fluoride [NaF]) or a placebo dentifrice with no fluoride. Fifty participants wearing a palatal appliance holding surface-softened bovine enamel specimens brushed their natural teeth with their assigned dentifrice. Specimens were removed at 5-, 10-, 15-, 30-, 60-, 120- and 240-min post brushing. Enamel remineralisation effect was evaluated at each timepoint by percent surface microhardness recovery (%SMHR) and enamel fluoride uptake (EFU). After a second in vitro erosive challenge, the percent relative erosion resistance (%RER) was calculated. Statistically significant differences in %SMHR were observed for the test dentifrice compared with the placebo dentifrice from the 60-min timepoint onwards (all p < 0.02; mean difference of 8.66 [95% CI 3.46, 13.87] at 60 min). At each specimen removal time, %RER and EFU were statistically significantly higher for the test dentifrice compared with the placebo dentifrice (p < 0.0001 for all). No treatment-related or serious adverse events were reported. The NaF-containing anti-erosion, dentin hypersensitivity dentifrice improved remineralisation of acid-softened enamel starting at 60 min of intra-oral exposure. It also improved enamel erosion resistance and fluoride uptake as early as 5 min after exposure to fluoridated dentifrice slurry. Brushing with a NaF-containing dentifrice can rapidly improve remineralisation, enamel erosion resistance and fluoride uptake.

Identifiants

pubmed: 30997568
doi: 10.1007/s00784-019-02900-5
pii: 10.1007/s00784-019-02900-5
doi:

Substances chimiques

Cariostatic Agents 0
Dentifrices 0
Sodium Fluoride 8ZYQ1474W7
Fluorides Q80VPU408O

Types de publication

Journal Article

Langues

eng

Pagination

4455-4463

Références

Caries Res. 2004 Jan-Feb;38(1):62-6
pubmed: 14684979
J Dent Res. 1984 Oct;63(10):1201-5
pubmed: 6592201
Oral Health Prev Dent. 2003;1(4):245-53
pubmed: 15643752
J Am Dent Assoc. 1986 Sep;113(3):383-8
pubmed: 3463611
Int Dent J. 2005;55(4 Suppl 1):285-90
pubmed: 16167607
Monogr Oral Sci. 2006;20:119-139
pubmed: 16687891
J Clin Dent. 2006;17(4):112-6
pubmed: 17131714
Caries Res. 2009;43(1):57-63
pubmed: 19204389
Caries Res. 1980;14(1):32-9
pubmed: 6927864
Caries Res. 2010;44(4):390-401
pubmed: 20699615
J Dent Res. 1992 Nov;71(11):1768-75
pubmed: 1401438
Caries Res. 2003 Nov-Dec;37(6):450-5
pubmed: 14571125
Monogr Oral Sci. 2011;22:146-157
pubmed: 21701197
Arch Oral Biol. 1971 May;16(5):535-48
pubmed: 5281124
J Dent Res. 1990 Feb;69 Spec No:620-5; discussion 634-6
pubmed: 2312892
Adv Oral Biol. 1966;2:149-71
pubmed: 5333761
Caries Res. 1991;25(2):123-9
pubmed: 2059973
Acta Odontol Scand. 1999 Dec;57(6):325-9
pubmed: 10777135
J Clin Dent. 2009;20(6):192-8
pubmed: 20131679
Caries Res. 2000 Jan-Feb;34(1):48-52
pubmed: 10601784
J Oral Rehabil. 1991 Nov;18(6):501-6
pubmed: 1762023
J Dent Res. 1992 Apr;71 Spec No:871-8
pubmed: 1592978
Caries Res. 1999 Nov-Dec;33(6):455-61
pubmed: 10529531
J Dent. 2001 Jul;29(5):371-6
pubmed: 11472810
J Dent Res. 1992 Sep;71(9):1546-52
pubmed: 1522285
Caries Res. 1979;13(2):80-3
pubmed: 285754
Monogr Oral Sci. 2011;22:158-170
pubmed: 21701198
Clin Oral Investig. 2005 Mar;9(1):52-7
pubmed: 15726445
Caries Res. 2016;50(1):62-70
pubmed: 26862746
Int Dent J. 2004;54(5 Suppl 1):304-9
pubmed: 15509081
J Am Dent Assoc. 2004 Feb;135(2):231-7
pubmed: 15005441

Auteurs

M Nehme (M)

GSK Consumer Healthcare, St George's Avenue, Weybridge, KT13 0DE, UK.

C R Parkinson (CR)

GSK Consumer Healthcare, St George's Avenue, Weybridge, KT13 0DE, UK. charles.x.parkinson@gsk.com.

D T Zero (DT)

Oral Health Research Institute, Indiana University School of Dentistry, Indianapolis, IN, USA.

A T Hara (AT)

Oral Health Research Institute, Indiana University School of Dentistry, Indianapolis, IN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH